BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9570992)

  • 1. Heat shock protein 27: an independent prognostic indicator of survival in patients with epithelial ovarian carcinoma.
    Geisler JP; Geisler HE; Tammela J; Wiemann MC; Zhou Z; Miller GA; Crabtree W
    Gynecol Oncol; 1998 Apr; 69(1):14-6. PubMed ID: 9570992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of heat shock protein 27 in endometrial carcinoma.
    Geisler JP; Geisler HE; Tammela J; Miller GA; Wiemann MC; Zhou Z
    Gynecol Oncol; 1999 Mar; 72(3):347-50. PubMed ID: 10053106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and bcl-2 in epithelial ovarian carcinoma: their value as prognostic indicators at a median follow-up of 60 months.
    Geisler JP; Geisler HE; Miller GA; Wiemann MC; Zhou Z; Crabtree W
    Gynecol Oncol; 2000 May; 77(2):278-82. PubMed ID: 10785478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up.
    Geisler JP; Tammela JE; Manahan KJ; Geisler HE; Miller GA; Zhou Z; Wiemann MC
    Eur J Gynaecol Oncol; 2004; 25(2):165-8. PubMed ID: 15032273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of p53 in epithelial ovarian cancer.
    Geisler JP; Geisler HE; Wiemann MC; Givens SS; Zhou Z; Miller GA
    Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
    Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
    Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma.
    Mese H; Sasaki A; Nakayama S; Yoshioka N; Yoshihama Y; Kishimoto K; Matsumura T
    Oncol Rep; 2002; 9(2):341-4. PubMed ID: 11836604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
    Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
    Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system.
    Shimizu Y; Kamoi S; Amada S; Hasumi K; Akiyama F; Silverberg SG
    Gynecol Oncol; 1998 Jul; 70(1):2-12. PubMed ID: 9698465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB-3 predicts survival in ovarian cancer.
    Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
    J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
    Kayastha S; Freedman AN; Piver MS; Mukkamalla J; Romero-Guittierez M; Werness BA
    Clin Cancer Res; 1999 May; 5(5):1073-6. PubMed ID: 10353740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK
    Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma.
    Schmider A; Gee C; Friedmann W; Lukas JJ; Press MF; Lichtenegger W; Reles A
    Gynecol Oncol; 2000 May; 77(2):237-42. PubMed ID: 10785471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.
    Kuhn W; Schmalfeldt B; Reuning U; Pache L; Berger U; Ulm K; Harbeck N; Späthe K; Dettmar P; Höfler H; Jänicke F; Schmitt M; Graeff H
    Br J Cancer; 1999 Apr; 79(11-12):1746-51. PubMed ID: 10206287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.